Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 13 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1

Interventions

Filgrastim 10 Cyclophosphamide 8 Granulocyte Colony-Stimulating Factor 6 Melphalan 5 Busulfan 5 Vincristine 4 Topotecan 4 Temozolomide 4 Stem Cell Transplantation 4 Peripheral Blood Stem Cell Transplantation 4 Ifosfamide 4 Etoposide 4 Thiotepa 3 Radiotherapy 3 Mesna 3 Itraconazole 3 Doxorubicin 3 Cisplatin 3 Carboplatin 3 sargramostim 2 fludarabine 2 Therapeutics 2 Sirolimus 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Drug Therapy 2 Bone Marrow Transplantation 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2 trioctyl phosphine oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Wilms Tumor × Data Collection × Clear all

NCT04423484 2026-03-02

GFANEPHRO20

French Africa Pediatric Oncology Group

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡